BioTechGrid – Page 2322

Insilico Medicine licenses 2nd AI-generated cancer drug candidate to Menarini’s Stemline in $550M deal

January 9, 2025

Another new year, another half-billion-biobuck transaction between Insilico Medicine and the Italian drugmaker Menarini Group. Following a licensing agreement last…

Biotechnology

Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A

January 9, 2025

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis…

Biotechnology

GSK-backed Ouro Medicines launches into T-cell engager space with $115M and a clinical-stage asset

January 9, 2025

Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager (TCE)…

Biotechnology

Moderna co-founder Chien’s new biotech inks $950M RNA deal with Etherna

January 9, 2025

Young biotech Dropshot Therapeutics has hooked in Etherna Immunotherapies with an RNA pact that could net up to $950 million.…

Medical Technology

Illumina rolls out single-cell & single-flow cell kits for low-volume labs

January 9, 2025

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making…

Genetics

New Prime Editing System, mvGPT, Combines Editing and Regulation

January 9, 2025

A new genome editing tool—minimal versatile genetic perturbation technology (mvGPT)—can achieve simultaneous and orthogonal gene editing and gene regulation in…

Medical Technology

Vensana Capital keeps up momentum with third medtech investment fund, raising $425M

January 9, 2025

The venture firm Vensana Capital has raised its third medtech-focused fund in the past six years, with $425 million in…

Biotechnology

After rejection, Vanda CEO pens searing letter to FDA commissioner about ‘disturbing pattern of conduct’

January 9, 2025

After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, M.D., is calling…

Biotechnology

Breakthrough Discovery Enhances Efficiency and Stability of Organic Solar Cells

January 9, 2025

In a groundbreaking advancement for renewable energy technology, researchers at Åbo Akademi University in Finland have made significant strides in…

Biotechnology

Lilly crafts deal for up to 5 new ALS antibodies with UK biotech Alchemab

January 9, 2025

It’s been a rough month for several clinical amyotrophic lateral sclerosis (ALS) candidates, but that’s not stopping Eli Lilly from…

Weight Loss Program Helps Obese Teenagers Breathe Easier at Rest and During Exercise

Mirror Trick Lets AI Learn Messy Networks Without Any Labels

Loneliness Erodes Bone: Isolation Weakens Male Mice Skeletons but Spares Females

Hidden Elbow Fracture in Babies: One X-ray Clue Stands Out, Study Finds

Cross Reality Seeks a Foothold on the Factory Floor, but the Evidence Is Still Thin

Europe’s Paediatric Researchers Unite as ESPR and EAP Launch First Joint Congress

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Insilico Medicine licenses 2nd AI-generated cancer drug candidate to Menarini’s Stemline in $550M deal

Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A

GSK-backed Ouro Medicines launches into T-cell engager space with $115M and a clinical-stage asset

Moderna co-founder Chien’s new biotech inks $950M RNA deal with Etherna

Illumina rolls out single-cell & single-flow cell kits for low-volume labs

New Prime Editing System, mvGPT, Combines Editing and Regulation

Vensana Capital keeps up momentum with third medtech investment fund, raising $425M

After rejection, Vanda CEO pens searing letter to FDA commissioner about ‘disturbing pattern of conduct’

Breakthrough Discovery Enhances Efficiency and Stability of Organic Solar Cells

Lilly crafts deal for up to 5 new ALS antibodies with UK biotech Alchemab

Adagio Medical kicks off strategic review, trims more than half its staff

Grail survives adcomm vote as it awaits FDA decision for cancer blood test

Siemens Healthineers and Novo team up on fatty liver disease awareness, testing

Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device